Women with HFrEF do better on lower-dose meds

A sex-specific approach to therapy is needed, researchers say

Women with heart failure achieve significantly better outcomes from half the recommended dose of ACE inhibitors, angiotensin-receptor blockers and beta blockers than men, a Dutch-led study suggests.